News

Press Releases

1. Luxembourg/Heidelberg, July 24, 2025

   European Investment Bank Backs Precisis with €20M Loan to Advance Breakthrough Neurostimulation Therapy in UK, Europe and US Markets

   Precisis announced today the closing of a €20 million venture loan from the European Investment Bank (EIB)

   Read more
2. Heidelberg, July 1, 2025

   Precisis focuses on international growth: Steven Griffiths appointed VP European Sales

   Precisis, the Heidelberg-based MedTech company specializing in neuromodulation, has appointed Steven Griffiths as Vice President European Sales

   Read more
3. Heidelberg, May 22, 2025

   Two Years, Real Results: EASEE® Therapy Brings Lasting Relief to People with Drug-Resistant Epilepsy

   For people living with drug-resistant epilepsies, every day can feel uncertain. But a newly published long-term study offers a powerful message of hope: our EASEE® system has demon […]

   Read more
4. Newcastle, May 2, 2025

   First UK Patient Received Revolutionary EASEE® Implant

   Precisis is proud to announce a significant milestone in epilepsy treatment with the first UK patient undergoing surgery to fit the revolutionary EASEE® implant at the Royal Infirm […]

   Read more
5. Heidelberg, October 17, 2024

   EASEE® System Successfully Implanted at Coimbra University Hospital

   We are proud to announce a significant advancement in epilepsy treatment with the first successful implantation of our EASEE® epilepsy system at Coimbra University Hospital in Port […]

   Read more
6. Heidelberg, October 16, 2024

   Precisis Celebrates Second Place at the HEALTH-i Award 2024

   We are thrilled to announce that Precisis has achieved second place at the prestigious HEALTH-i Award 2024, a significant milestone in our journey towards revolutionizing epilepsy […]

   Read more
7. Berlin, September 13, 2024

   PEARL Study Initiated to Assess the Long-Term Effects of the EASEE® Brain Stimulator – 135 People with Epilepsy* Can Participate

   Technological devices that deliver electrical pulses to nerve tissue—known as neurostimulation therapies—have already helped many people alleviate chronic pain. Many Parkinson's pa […]

   Read more
8. Heidelberg/Berlin, September 3, 2024

   MedTech Company Precisis Expands with Appointment of Top Executive as New CEO

   Leading Neuromodulation Company, PRECISIS GmbH, Appoints Karl Stoklosa as New CEO Karl Stoklosa has been appointed as the new CEO of PRECISIS GmbH, a leading company in the field o […]

   Read more
9. Heidelberg, July 1, 2024

   PRECISIS Unveils its Brain Pacemaker EASEE® III with Extended Three-Years Battery Life

   From the heart of Heidelberg, PRECISIS, a leader in neuromodulation, proudly announces a significant leap in epilepsy treatment with the launch of EASEE® III.

   Read more
10. Heidelberg, June 11, 2024

    Precisis has introduced EASEE® to Portugal in collaboration with Pagaimo Medical

    Precisis GmbH, a leading company in medical technology, has introduced EASEE®, a groundbreaking brain pacemaker for drug-resistant epilepsies, in Portugal in partnership with Pagai […]

    Read more